How should I evaluate and manage a patient with pruritus sine materia (itch without visible skin lesions)?

Evaluation and Management of Pruritus Sine Materia

Begin with a systematic diagnostic workup to identify underlying systemic causes before considering idiopathic or psychogenic etiologies, as approximately 50% of cases have an identifiable cause that requires specific treatment.

Initial Diagnostic Approach

Essential History Elements

Take a comprehensive history focusing on 1:

• Timing: Duration, pattern (constant vs. intermittent), nocturnal worsening
• Associated symptoms: Weight loss, fevers, night sweats (suggests lymphoma), fatigue
• Medication review: All prescription, over-the-counter, and herbal supplements
• Travel history: Exposure to parasitic infections
• Sexual history and IV drug use: HIV risk assessment
• Triggers: Water contact (aquagenic pruritus suggests polycythemia vera)

Physical Examination

Examine thoroughly for secondary lesions from scratching (excoriations, lichenification) while confirming absence of primary dermatologic disease. Check 1:

• Lymph nodes (lymphoma)
• Hepatosplenomegaly
• Jaundice or scleral icterus
• Signs of chronic liver or kidney disease

Laboratory Investigation Algorithm

First-Line Testing (All Patients)

1:

• Complete blood count with differential and blood film
• Ferritin levels (iron deficiency is a common, treatable cause)
• Renal function: Urea, creatinine, electrolytes
• Liver function tests: Consider bile acids and antimitochondrial antibodies
• Fasting glucose or HbA1c
• Lactate dehydrogenase and ESR (if hematologic malignancy suspected)

Second-Line Testing (Based on Clinical Suspicion)

1:

• JAK2 V617F mutation if polycythemia vera suspected (raised hemoglobin/hematocrit with microcytosis)
• HIV and hepatitis A, B, C serology (especially with risk factors)
• Thyroid function only if clinical features suggest endocrinopathy
• Chest X-ray if systemic symptoms present
• Skin biopsy from trunk in persistent unexplained cases (rare cutaneous lymphoma can present without visible lesions)

Important caveat: Do NOT perform routine endocrine screening or extensive malignancy workup without specific clinical indicators 1.

Treatment Strategy by Etiology

For Generalized Pruritus of Unknown Origin (GPUO)

When no cause identified after thorough workup 1:

First-line therapy:

• Emollients liberally and self-care advice
• Topical menthol or clobetasone butyrate
• Topical doxepin (limit to 8 days, <10% body surface area, max 12g daily)

Avoid: Crotamiton cream (Strength B), capsaicin, or calamine lotion 1

Second-line systemic therapy:

• Non-sedating antihistamines: Fexofenadine 180mg or loratadine 10mg daily
• Consider H1 + H2 combination (e.g., fexofenadine + cimetidine)
• SSRIs: Paroxetine, fluvoxamine, or mirtazapine
• Gabapentin or pregabalin
• Naltrexone, ondansetron, or aprepitant

Sedating antihistamines (hydroxyzine) only for short-term or palliative use—long-term use may predispose to dementia 1

Specific Etiologies

Iron deficiency: Iron replacement (Strength C) 1

Uraemic pruritus 1:

• Optimize dialysis, normalize calcium-phosphate, control PTH, correct anemia
• Broadband UVB phototherapy (Strength A—highest quality evidence)
• Consider gabapentin or topical capsaicin
• Avoid cetirizine (not effective) and long-term sedating antihistamines

Hepatic/cholestatic pruritus 1:

1. Rifampicin first-line (Strength A)
2. Cholestyramine second-line
3. Sertraline third-line
4. Naltrexone or nalmefene fourth-line
5. Do NOT use gabapentin in hepatic pruritus

Polycythemia vera 1:

• Aspirin 300mg daily, interferon-alpha, SSRIs
• Phototherapy (NB-UVB, BB-UVB, or PUVA)
• Ruxolitinib (JAK1/JAK2 inhibitor) highly effective

Lymphoma-associated 1:

• Gabapentin, carbamazepine, mirtazapine, or cimetidine
• Phototherapy (BB-UVB for Hodgkin, NB-UVB for non-Hodgkin)
• Oral corticosteroids for incurable disease

Drug-induced pruritus 1:

• Trial cessation if risk-benefit acceptable
• Opioid-induced: Naltrexone first-line (Strength B); alternatives include methylnaltrexone, ondansetron, mirtazapine, gabapentin
• Chloroquine-induced: Prednisolone 10mg, niacin 50mg, or dapsone

Neuropathic pruritus: Refer to neurology/pain specialist 1

Psychogenic Considerations

Critical principle: Always exclude physical causes before labeling as psychogenic 1. Psychiatric disorders (depression, anxiety, OCD) commonly develop secondary to chronic pruritus in up to one-third of patients.

When psychogenic suspected 1:

• Consider psychosocial/behavioral interventions: habit reversal training, cognitive restructuring, relaxation techniques
• Refer to liaison psychiatry or psychology
• Patient support groups beneficial
• NB-UVB phototherapy may help functional itch disorder

Referral Indications

Refer to secondary care if 1:

• Diagnostic uncertainty persists
• Primary care management fails to relieve symptoms
• Suspected hematologic malignancy (refer to hematology)
• Significant hepatic impairment (refer to hepatology)
• Neuropathic features requiring specialist input

Common Pitfalls to Avoid

1. Premature psychiatric diagnosis without excluding systemic causes 1
2. Routine malignancy screening without specific clinical indicators (low yield, not cost-effective) 1
3. Long-term sedating antihistamines (dementia risk) 1
4. Using gabapentin for hepatic pruritus (ineffective) 1
5. Missing iron deficiency (check ferritin in all patients) 1
6. Overlooking medication causes (obtain complete drug history including OTC) 1